Sarepta Therapeutics
SRPT
SRPT
373 hedge funds and large institutions have $9.25B invested in Sarepta Therapeutics in 2022 Q3 according to their latest regulatory filings, with 81 funds opening new positions, 122 increasing their positions, 112 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
373
Holders Change
+44
Holders Change %
+13.37%
% of All Funds
6.45%
Holding in Top 10
10
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+11.11%
% of All Funds
0.17%
New
81
Increased
122
Reduced
112
Closed
36
Calls
$269M
Puts
$160M
Net Calls
+$109M
Net Calls Change
+$57.4M
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$633M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$105M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$97.6M |
| 4 |
Two Sigma Investments
New York
|
+$83.9M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$81.8M |
Top Sellers
| 1 |
Sands Capital Management
Arlington,
Virginia
|
-$136M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$52.1M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$47.5M |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$42.4M |
| 5 |
State Street
Boston,
Massachusetts
|
-$42.2M |
